Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-010 · Scope and validity
PC-VAL-01: Hormonal contraception limits interpretation
Hormonal contraception limits interpretation. Evaluates combined hormonal contraception taken now or in the last 3 months.
Condition
- combined hormonal contraception taken now or in the last 3 months
What it reports
- Cycles and androgen levels are altered: PCOS cannot be reliably assessed on the cycle or on testosterone
Recommended next steps (for physician review)
- If the risks are acceptable, reassess after contraception is stopped for about 3 months; otherwise rely on clinical features and history
Diagnostic boundary
- The decision to pause contraception belongs to the physician and patient.
Evidence
- EV-PCOS-2023Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469.Supports: Adult diagnosis: irregular cycles plus hyperandrogenism once other causes are excluded; ultrasound or AMH when one is missing Adolescent criteria require both irregular cycles and hyperandrogenism Glycemic, cardiometabolic, sleep and mood assessment; endometrial risk in prolonged anovulation
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.